subject area of
- A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non–Small-Cell Lung Cancer Journal Articles
- A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149) Journal Articles
- Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer Journal Articles
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome Journal Articles
- Method to Our Madness or Madness in Our Methods? Pitfalls in Trial Methodology Journal Articles
- Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC Journal Articles
- Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer Journal Articles
- Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC Journal Articles
- Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations Journal Articles
- Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors Journal Articles
- Phase I Targeted Combination Trial of Sorafenib and Erlotinib in Patients with Advanced Solid Tumors Journal Articles
- Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study Conferences
- Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148 Journal Articles
- Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer Journal Articles
- Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib Journal Articles
- Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Journal Articles
- Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer Journal Articles
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis Journal Articles
- Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how? Journal Articles
- Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation Journal Articles
- Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic review. Journal Articles